P1.08-01 CoxMoE: A Deep Learning Model Predicts Survival and Response in T790M Positive NSCLC Patients Treated with Third-Generation EGFR-TKI

N. Lou, X. Cui, X. Lin,R. Gao, C. Xu, N. Qiao,J. Jiang,L. Wang, W. Wang, S. Wang, W. Shen, X. Zheng, P. Hu

Journal of Thoracic Oncology（2023）

引用 0|浏览7

暂无评分

摘要

Presented epidermal growth factor receptor (EGFR) sensitive mutations are strong predictors for treatment response to EGFR tyrosine kinase inhibitors (TKIs). The most common genotype variation for first-and second-generation EGFR-TKI resistance is EGFR T790M mutation.

查看译文

关键词

nsclc patients,coxmoe,third-generation,egfr-tki

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要